MMP-3 polymorphism: Genetic marker in pathological processes (Review)

F B A Munhoz1, A L Godoy-Santos, M C L G Santos

  • 1Department of Cell Biology, University Federal of Paraná, Curitiba PR, Brazil.

Insights

Matrix metalloproteinases (MMPs), specifically MMP-3, are crucial enzymes in tissue remodeling. A common 5A/6A gene variant influences MMP-3 activity and may serve as a disease susceptibility marker.

Area of Science:

  • Biochemistry and Molecular Biology
  • Genetics and Genomics
  • Pathology and Disease Mechanisms

Background:

  • Matrix metalloproteinases (MMPs) are essential zinc-dependent endopeptidases involved in extracellular matrix (ECM) degradation.
  • MMP activity is tightly regulated, with transcriptional control being a key regulatory mechanism.
  • MMP-3, a prominent member of the MMP family, possesses broad substrate specificity and is vital for connective tissue remodeling and ECM turnover.

Purpose of the Study:

  • To review the role of MMP-3 in various pathological processes.
  • To focus on the functional 5A/6A promoter polymorphism of MMP-3.
  • To explore the potential of this polymorphism as a genetic marker for disease susceptibility.

Main Methods:

  • Literature review of studies on MMP-3 and its functional polymorphism.
  • Analysis of the impact of the MMP-3 5A/6A polymorphism on enzyme activity.
  • Examination of associations between the MMP-3 5A/6A polymorphism and various diseases.

Main Results:

  • The 5A/6A polymorphism in the MMP-3 gene promoter is a common functional variant.
  • This polymorphism affects MMP-3 activity and its role in ECM remodeling.
  • The MMP-3 5A/6A polymorphism has been linked to the susceptibility of several diseases.

Conclusions:

  • MMP-3 plays a significant role in pathological processes, particularly in connective tissue remodeling.
  • The 5A/6A polymorphism represents a key genetic factor influencing MMP-3 activity.
  • This polymorphism holds potential as a predictive biomarker for individual disease risk.